Malignancy After Liver Transplantation: Cumulative Risk for Development

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2447-2449

  Marques Medina E ^a   Jimenez Romero C ^a   Gomez de la Camara A ^a   Rota Bernal, A ^b   Manrique Municio, A ^a   Moreno Gonzalez E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; STEROID; TACROLIMUS;

ADULT; ARTICLE; CADAVER DONOR; CANCER RISK; DIGESTIVE SYSTEM CANCER; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LARYNX CANCER; LIVER TRANSPLANTATION; LUNG CANCER; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CANCER; STOMACH CANCER; UROGENITAL TRACT CANCER;

ADULT; CONFIDENCE INTERVALS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 68949208495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.153     Document Type: Article

References (4)

1. Jiménez-Romero C., Manrique Municio A., Marqués Medina E., et al. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases. Transplant Proc 38 (2006) 2505
2. Jonas S., Rayes N., Neumann U., et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 80 (1997) 1141
3. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population based study. J Hepatol 34 (2001) 84
4. Herrero J.I., Lorenzo M., Quiroga J., et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 11 (2005) 897